Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ALXO stock hub

ALX Oncology Holdings Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ALXOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

279.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ALXO

In the news

Latest news · ALXO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-74.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-41.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ALXO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

187

Groups with data

Currency

USD

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001810182
Company name	ALX Oncology Holdings Inc.
Country	United States
Country code	US
Cusip	00166B105
Employees	43
Employees Change	-37%
Employees Change Percent	-46.25
Enterprise value	$148.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-07-17
Isin	US00166B1052
Last refreshed	2026-05-10
Market cap	$279.9M
Market cap category	Micro-Cap
Price	$2.08
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	ALXO
Website	https://www.alxoncology.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-31.75%
FCF yield	-27.99%
P/B ratio	1.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-88.9M
Net Income Growth Quarters	7%
Net Income Growth Years	2%
Profit Per Employee	$-2.1M
ROA	-36.76
Roa5y	-36.27
ROCE	-55.64
ROE	-74.17
Roe5y	-73.21
ROIC	-41.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	330.09%
Cagr3y	-31.13%
Cagr5y	-49.76%
EPS Growth Quarters	9
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$178.3M
Cash	$140.3M
Current Assets	$145.6M
Current Liabilities	$20.2M
Debt	$8.5M
Debt Equity	$0.06
Equity	$151.3M
Interest Coverage	-57.62
Liabilities	$27M
Long Term Assets	$32.8M
Long Term Liabilities	$6.8M
Net Cash	$131.8M
Net Cash By Market Cap	$47.1
Net Cash Growth	62.24%
Net Debt Equity	$-0.87
Tangible Book Value	$151.3M
Tangible Book Value Per Share	$1.12
WACC	6.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.21
Net Working Capital	$-9.7M
Quick ratio	6.95
Working Capital	$125.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-25.44%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	329.66%
200-day SMA	1.54
3Y total return	-67.35%
50-day SMA	1.92
50-day SMA vs 200-day SMA	50over200
5Y total return	-96.8%
All Time High	117.5
All Time High Change	-98.23%
All Time High Date	2020-12-10
All Time Low	0.4
All Time Low Change	414.85%
All Time Low Date	2025-06-27
ATR	0.17
Beta	0.41
Beta1y	0.5
Beta2y	1.35
Ch YTD	84.07
High	2.11
High52	2.66
High52 Date	2026-02-19
High52ch	-21.8%
Low	1.76
Low52	0.4
Low52 Date	2025-06-27
Low52ch	414.85%
Ma50ch	8.22%
Premarket Change Percent	1.07
Premarket Price	$1.89
Premarket Volume	9,512
Price vs 200-day SMA	34.72%
RSI	59.91
RSI Monthly	43.95
RSI Weekly	57.77
Sharpe ratio	1.75x
Sortino ratio	3.34
Total Return	-25.44%
Tr YTD	84.07
Tr1m	13.66%
Tr1w	23.08%
Tr3m	1.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	3
Analyst Price Target Top	$4.33
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.16
Operating Income	$-88M
Price target	$3.5
Price Target Change	$68.27
Price Target Change Top	$108

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	107,014,762%
Float Percent	79.53%
Net Borrowing	-2,669,000
Shares Insiders	1.23%
Shares Institutions	19.56%
Shares Out	134,559,917
Shares Qo Q	92.64%
Shares Yo Y	25.44%
Short Float	1.91%
Short Ratio	2.09
Short Shares	1.52

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-88.2M
Average Volume	1,068,517.05x
Bv Per Share	1.12
CAPEX	$-202,000
Ch1m	13.66
Ch1w	23.08
Ch1y	329.7
Ch3m	1.46
Ch3y	-67.35
Ch5y	-96.8
Ch6m	50.73
Change	11.23%
Change From Open	10.05
Close	1.87
Days Gap	1.07
Depreciation Amortization	645,000
Dollar Volume	2,077,104.6
Earnings Date	2026-05-08
Earnings Time	bmo
EBIT	$-88M
EBITDA	$-87.3M
EPS	$-1.34
F Score	3
FCF	$-78.3M
FCF EV Yield	-52.9x
FCF Per Share	$-0.58
Financing CF	139,892,000
Fiscal Year End	December
Founded	2,015
Investing CF	-50,095,000
Ipr	-89.05
Iprfo	-94.3
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-09
Ma150	1.72
Ma150ch	21.28%
Ma20	1.74
Ma20ch	19.33%
Net CF	11,670,000
Next Earnings Date	2026-08-11
Open	1.89
Optionable	Yes
Position In Range	92.75
Post Close	2.08
Postmarket Change Percent	-5.77
Postmarket Price	$1.96
Ppne	1,050,000
Pre Close	1.87
Price Date	2026-05-08
Ptbv Ratio	1.85
Relative Volume	0.93x
Share Based Comp	9,872,000
Tr6m	50.73%
Us State	California
Volume	998,608

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ALXO pay a dividend?

Capital-return profile for this ticker.

Performance

ALXO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ALXO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.6%

Float: +79.5% of shares outstanding

Insider ownership

+1.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ALXO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.9

Neutral momentum band

Price vs 200-day MA

+34.7%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

1.75

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ALXO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ALXO stock rating?

ALX Oncology Holdings Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ALXO analysis?

The full report lives at /stocks/ALXO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ALXO?

The latest report frames ALXO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ALXO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.